phosphorylcholine has been researched along with Blood Poisoning in 12 studies
Phosphorylcholine: Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction.
phosphocholine : The phosphate of choline; and the parent compound of the phosphocholine family.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with acute respiratory distress syndrome (ARDS) have a deficiency of surfactant." | 2.68 | Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group. ( Anzueto, A; Baughman, RP; Guntupalli, KK; Lemaire, F; Long, W; Pattishall, EN; Raventós, AA; Weg, JG; Wiedemann, HP; Zaccardelli, DS, 1996) |
| "Miltefosine was orally administered at doses of 15 and 30 mg/kg/day after, at the time of, and before bacterial challenge for 3-5 days." | 1.35 | In vitro and in vivo activity of miltefosine against penicillin-sensitive and -resistant Streptococcus pneumoniae strains. ( Del Prado, G; Gracia, M; Huelves, L; Ponte, C; Rodríguez-Cerrato, V, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 4 (33.33) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, Z | 1 |
| Abrams, ST | 1 |
| Toh, J | 1 |
| Wang, SS | 1 |
| Downey, C | 1 |
| Ge, X | 1 |
| Yu, Q | 1 |
| Yu, W | 1 |
| Wang, G | 1 |
| Toh, CH | 1 |
| Ramos-Sevillano, E | 1 |
| Urzainqui, A | 1 |
| Campuzano, S | 1 |
| Moscoso, M | 1 |
| González-Camacho, F | 1 |
| Domenech, M | 1 |
| Rodríguez de Córdoba, S | 1 |
| Sánchez-Madrid, F | 1 |
| Brown, JS | 1 |
| García, E | 1 |
| Yuste, J | 1 |
| Gang, TB | 1 |
| Hanley, GA | 1 |
| Agrawal, A | 1 |
| Huelves, L | 1 |
| Del Prado, G | 1 |
| Gracia, M | 1 |
| Rodríguez-Cerrato, V | 1 |
| Ponte, C | 1 |
| Ferguson, LM | 1 |
| Dreisbach, AW | 1 |
| Csongrádi, E | 1 |
| Juncos, LA | 1 |
| Fulop, T | 1 |
| McDaniel, LS | 1 |
| Benjamin, WH | 1 |
| Forman, C | 1 |
| Briles, DE | 1 |
| Doig, C | 1 |
| Weg, JG | 2 |
| Balk, RA | 1 |
| Tharratt, RS | 1 |
| Jenkinson, SG | 1 |
| Shah, JB | 1 |
| Zaccardelli, D | 1 |
| Horton, J | 1 |
| Pattishall, EN | 2 |
| Anzueto, A | 1 |
| Baughman, RP | 1 |
| Guntupalli, KK | 1 |
| Wiedemann, HP | 1 |
| Raventós, AA | 1 |
| Lemaire, F | 1 |
| Long, W | 1 |
| Zaccardelli, DS | 1 |
| Imperatore, F | 1 |
| Postiglione, M | 1 |
| Diurno, F | 1 |
| Cirillo, F | 1 |
| Liguori, G | 1 |
| Pica, M | 1 |
| Speer, CP | 1 |
| Robertson, B | 1 |
| Halliday, HL | 1 |
| Kukkonen, AK | 1 |
| Virtanen, M | 1 |
| Järvenpää, AL | 1 |
| Pokela, ML | 1 |
| Ikonen, S | 1 |
| Fellman, V | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Clinical Trial of Nebulized Surfactant for the Treatment of Moderate to Severe COVID-19[NCT04362059] | 20 participants (Actual) | Interventional | 2020-06-18 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for phosphorylcholine and Blood Poisoning
| Article | Year |
|---|---|
Safety and potential efficacy of an aerosolized surfactant in human sepsis-induced adult respiratory distress syndrome.
Topics: Adult; Aerosols; Aged; APACHE; Double-Blind Method; Drug Administration Schedule; Drug Combinations; | 1994 |
Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group.
Topics: Administration, Inhalation; Aerosols; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female | 1996 |
Randomized trial comparing natural and synthetic surfactant: increased infection rate after natural surfactant?
Topics: Biological Products; C-Reactive Protein; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, | 2000 |
9 other studies available for phosphorylcholine and Blood Poisoning
| Article | Year |
|---|---|
Complexes between C-Reactive Protein and Very Low Density Lipoprotein Delay Bacterial Clearance in Sepsis.
Topics: Aged; Animals; Bacteremia; C-Reactive Protein; Disease Models, Animal; Female; Humans; Kupffer Cells | 2020 |
Pleiotropic effects of cell wall amidase LytA on Streptococcus pneumoniae sensitivity to the host immune response.
Topics: Animals; Bacterial Capsules; Bacterial Proteins; Cell Wall; Complement Activation; Complement C3; Co | 2015 |
C-reactive protein protects mice against pneumococcal infection via both phosphocholine-dependent and phosphocholine-independent mechanisms.
Topics: Animals; Bacterial Load; C-Reactive Protein; Disease Models, Animal; Male; Mice, Inbred C57BL; Mutan | 2015 |
In vitro and in vivo activity of miltefosine against penicillin-sensitive and -resistant Streptococcus pneumoniae strains.
Topics: Animals; Anti-Bacterial Agents; Bacteriological Techniques; Dose-Response Relationship, Drug; Mice; | 2008 |
Recurring extracorporeal circuit clotting during continuous renal replacement therapy in fungal sepsis: successful treatment with argatroban.
Topics: Antifungal Agents; Antithrombins; Arginine; Blood Coagulation; Coronary Artery Bypass; Humans; Male; | 2013 |
Blood clearance by anti-phosphocholine antibodies as a mechanism of protection in experimental pneumococcal bacteremia.
Topics: Animals; Antibodies, Bacterial; Blood Bactericidal Activity; Choline; Dose-Response Relationship, Im | 1984 |
Aerosolized surfactant in sepsis-induced adult respiratory distress syndrome.
Topics: Drug Combinations; Fatty Alcohols; Humans; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfac | 1995 |
The instillated surfactant in the treatment of sepsis-induced ARDS: case report.
Topics: Bronchi; Drug Combinations; Fatty Alcohols; Humans; Phosphorylcholine; Polyethylene Glycols; Pulmona | 1999 |
Randomized trial comparing natural and synthetic surfactant: increased infection rate after natural surfactant?
Topics: Biological Products; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Infant, Premature; | 2000 |